Literature DB >> 8352346

Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery.

T E Goldberg1, J M Gold, R Greenberg, S Griffin, S C Schulz, D Pickar, J E Kleinman, D R Weinberger.   

Abstract

OBJECTIVE: This study was designed to ascertain the degree and specificity of cognitive impairments in patients with schizophrenia and patients with affective disorders.
METHOD: Cognitive function was assessed with a neuropsychological test battery in consecutively admitted patients with schizophrenia (N = 57), unipolar depression (N = 29), and bipolar disorder (N = 16).
RESULTS: The performance of the schizophrenic group was significantly below that of the groups with affective disorders on measures of attention and psychomotor speed, verbal and visual memory, and problem solving and abstraction. IQ was lower in the schizophrenic group and appeared to have deteriorated from a normal premorbid level that was not different from that of the affective disorder groups, as determined by the Wide Range Achievement Test--Revised reading test, a putative measure of premorbid intelligence. When IQ was controlled, differences between the groups in problem solving and visual memory remained. Psychiatric symptoms had a larger impact on test performance in the affective disorder groups than in the schizophrenic group.
CONCLUSIONS: These results suggest that patients with schizophrenia perform systematically worse on cognitive measures than patients with affective disorders, which is consistent with their generally poorer outcome. The results also indicate that schizophrenia and affective disorders are qualitatively distinguishable in neuropsychological terms, given differences in apparent intellectual deterioration, profiles of cognitive impairment, and associations between cognitive performance and psychopathology.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8352346     DOI: 10.1176/ajp.150.9.1355

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  35 in total

1.  Reduced white matter integrity and verbal fluency impairment in young adults with bipolar disorder: a diffusion tensor imaging study.

Authors:  Isabelle E Bauer; Austin Ouyang; Benson Mwangi; Marsal Sanches; Giovana B Zunta-Soares; Richard S E Keefe; Hao Huang; Jair C Soares
Journal:  J Psychiatr Res       Date:  2015-02-07       Impact factor: 4.791

Review 2.  First- and second-generation antipsychotic medication and cognitive processing in schizophrenia.

Authors:  Thomas W Weickert; Terry E Goldberg
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

3.  Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met allele.

Authors:  Bo Cao; Isabelle E Bauer; Ajaykumar N Sharma; Benson Mwangi; Thomas Frazier; Luca Lavagnino; Giovana B Zunta-Soares; Consuelo Walss-Bass; David C Glahn; Flavio Kapczinski; David A Nielsen; Jair C Soares
Journal:  J Affect Disord       Date:  2016-03-10       Impact factor: 4.839

4.  Relationship between diagnosis and disposition of patients admitted to a state psychiatric hospital.

Authors:  Claire Advokat; Nancy Eustis; John Pickering
Journal:  Psychiatr Q       Date:  2005

5.  Clinical implications of cognitive function in bipolar disorder.

Authors:  C T Sudhir Kumar; Sophia Frangou
Journal:  Ther Adv Chronic Dis       Date:  2010-05       Impact factor: 5.091

6.  Verbal and visual-spatial memory impairment in youth at familial risk for schizophrenia or affective psychosis: a pilot study.

Authors:  Silvia Scala; Andrea Pousada; William S Stone; Heidi W Thermenos; Theo C Manschreck; Ming T Tsuang; Stephen V Faraone; Larry J Seidman
Journal:  Schizophr Res       Date:  2013-01-09       Impact factor: 4.939

Review 7.  Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms.

Authors:  Michael A Cirillo; Larry J Seidman
Journal:  Neuropsychol Rev       Date:  2003-06       Impact factor: 7.444

8.  Further exploration of M₁ allosteric agonists: subtle structural changes abolish M₁ allosteric agonism and result in pan-mAChR orthosteric antagonism.

Authors:  Douglas J Sheffler; Christian Sevel; Uyen Le; Kimberly M Lovell; James C Tarr; Sheridan J S Carrington; Hyekyung P Cho; Gregory J Digby; Colleen M Niswender; P Jeffrey Conn; Corey R Hopkins; Michael R Wood; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2012-11-09       Impact factor: 2.823

9.  A comparison of neuropsychological dysfunction in first-episode psychosis patients with unipolar depression, bipolar disorder, and schizophrenia.

Authors:  S Kristian Hill; James L Reilly; Margret S H Harris; Cherise Rosen; Robert W Marvin; Ovidio Deleon; John A Sweeney
Journal:  Schizophr Res       Date:  2009-05-17       Impact factor: 4.939

10.  A systematic review of the evidence of the burden of bipolar disorder in Europe.

Authors:  Liberty Fajutrao; Julie Locklear; Jennifer Priaulx; Anne Heyes
Journal:  Clin Pract Epidemiol Ment Health       Date:  2009-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.